TFF Pharmaceuticals, Inc.
USD0.07
-0.10 (-60.05%)
CEO
Harlan F. Weisman
IPO Date
2019-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.09
Prev. Close
$0.16
Day Low
$0.06
Day High
$0.09
52W Low
$0.06
52W High
$11.00
Market Cap
$0.00B
Volume
11.02M
| 3,165 |
| $1.82 |
| 8 Jul 2024 | Lee Catherine Chai-zon | director | A-Award | Acquired | 1,583 | $0.00 |
| 8 Jul 2024 | Lee Catherine Chai-zon | director | A-Award | Acquired | 1,583 | $1.82 |
| 8 Jul 2024 | Roberts Brandi | director | A-Award | Acquired | 3,165 | $0.00 |
| 8 Jul 2024 | Roberts Brandi | director | A-Award | Acquired | 3,165 | $1.82 |
| 8 Jul 2024 | KING THOMAS BRAXTON | director | A-Award | Acquired | 1,583 | $0.00 |
| 8 Jul 2024 | KING THOMAS BRAXTON | director | A-Award | Acquired | 1,583 | $1.82 |
| 8 Jul 2024 | COLEMAN KIRK ALLEN | Chief Financial Officer | A-Award | Acquired | 10,184 | $0.00 |
| 8 Jul 2024 | COLEMAN KIRK ALLEN | Chief Financial Officer | A-Award | Acquired | 10,184 | $1.82 |